Clinical Trial Update: A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) [Phase 3]

View source ↗

Summary

A Phase 3 trial (EXHALE-3) evaluating dexpramipexole for severe eosinophilic asthma in adolescents and adults has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilic Asthma

Drugs mentioned

• Dexpramipexole (dexpramipexole)

Snippet

Sponsor: Areteia Therapeutics | Conditions: Eosinophilic Asthma, Asthma; Eosinophilic | Phase 3 | Status: TERMINATED